Drugs / CH-1504 L-ISOMER
CH-1504 L-ISOMER
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01116141 | Sep 2010 → Apr 2012 | rheumatoid arthritis | Chelsea Therapeutics | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CH-1504 L-ISOMER | ChEMBL registry synonym — accepted as the source's own label CHEMBL4802147 ↗ |
| Known as | CH-4051 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01116141 ↗ |
| Known as | L-CH 1504 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4802147 ↗ |
| Known as | L-m-trex | ChEMBL registry synonym — accepted as the source's own label CHEMBL4802147 ↗ |
| Known as | L-mobiletrex | ChEMBL registry synonym — accepted as the source's own label CHEMBL4802147 ↗ |
| Modality | Small molecule | — CHEMBL4802147 ↗ |